Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39365

DNAL4 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The DNAL4 Knockout HeLa Polyclonal Cells provide a CRISPR/Cas9-edited population with disrupted DNAL4, a light intermediate chain of the axonemal outer dynein arm. Derived from HPV18-positive HeLa cervical carcinoma cells, this model enables dissection of dynein complex assembly and ciliary motility defects relevant to primary ciliary dyskinesia. DNAL4 interacts with DNAH5, DNAI1, and other dynein subunits, and its loss impairs outer dynein arm function. Applications include co-immunoprecipitation, immunofluorescence, and transcriptomic analyses of ciliogenic pathways, making these cells ideal for ciliopathy research, dynein assembly studies, and drug target validation. By providing a tractable system to study DNAL4 biology, this knockout resource advances both basic and translational investigations into motile cilia disorders.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    DNAL4

    Gene Identifier

    NCBI Gene ID 10126

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAL4 Knockout HeLa Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal cell population with targeted disruption of the DNAL4 gene in HeLa cells. This loss-of-function model eliminates DNAL4 protein expression, providing a robust platform to investigate the molecular role of this dynein component in ciliary biology. The polyclonal format avoids clonal bias, ensuring a heterogeneous genetic background that better reflects population-level responses in functional assays.

The host HeLa line, an HPV18-positive cervical adenocarcinoma cell line, is a widely used epithelial cancer model valued for its rapid growth and genetic tractability. Although HeLa cells are not inherently ciliated, they can be induced to form primary cilia by serum withdrawal, enabling studies of ciliary protein assembly and dynein complex formation. This background makes the DNAL4 knockout particularly useful for dissecting outer dynein arm assembly in a simplified cellular context.

DNAL4 encodes a light intermediate chain of the outer dynein arm of motile cilia. Under the transcriptional control of ciliogenic regulators RFX2 and FOXJ1, DNAL4 is integrated into the dynein motor complex alongside subunits such as DNAH5, DNAI1, and DNALI1. Disruption of DNAL4 destabilizes outer dynein arm assembly, leading to impaired ciliary beat and defective mucociliary clearance as seen in primary ciliary dyskinesia. This knockout thus recapitulates a critical ciliopathy phenotype at the molecular level.

Within the HeLa model, the DNAL4 knockout allows focused analysis of outer dynein arm biogenesis independent of multiciliated tissue complexity. The loss of DNAL4 provides a clean system to examine how dynein subunits interact and to map the hierarchical steps of arm assembly. Additionally, HeLa cells support the study of potential non-ciliary functions of DNAL4, given the emerging roles of ciliary proteins in cell cycle and cancer, thereby expanding the model??s utility beyond classical ciliopathy research.

Typical applications include co-immunoprecipitation and western blotting to evaluate dynein complex integrity, immunofluorescence microscopy to assess DNAL4 localization under ciliogenic conditions, and RT-qPCR to measure changes in ciliary transcription programs. This polyclonal knockout cell population is also suitable for primary ciliary dyskinesia modeling, drug screening for ciliary dysfunction, and studying DNAL4??s role in oncogenic pathways. For further information or procurement, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)